000 03874nam a22004455i 4500
999 _c10663
_d10663
001 10663
003 DE-He213
005 20210615040626.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 180301s2018 si | s |||| 0|eng d
020 _a9789811014123
024 7 _a10.1007/978-981-10-1412-3
_2doi
040 _bspa
_dES-MaUEC
050 _aRJ496 .C45
_b2018 EB
090 4 _aRJ1-570
245 0 0 _aCell Therapy for Perinatal Brain Injury
_cedited by Haruo Shintaku, Akira Oka, Makoto Nabetani.
264 1 _aSingapore
_bSpringer Singapore :
_bImprint: Springer
_c2018.
300 _a1 recurso en línea ( XII, 150 p.)
336 _2rdacontent
_aTexto (visual)
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
_2rda
490 _aMedicine (Springer-11650)
505 0 _a1. Clinical trial of autologous cord blood cell therapy for neonatal hypoxic‐ischemic encephalopathy (HIE) -- 2. New strategy of clinical studies for premature babies with ischemic brain damage -- 3. Pathophysiology and pathology of neonatal hypoxic-ischemic encephalopathy -- 4. Neural stem/progenitor cells for perinatal brain injury -- 5. Hematopoietic stem cells for perinatal brain injury -- 6. Umbilical cord-derived mesenchymal stromal cells for perinatal brain injury -- 7. Other tissues-derived mesenchymal stem cells for perinatal brain injury -- 8. CD34+ cell in cord blood and neonates -- 9. The History of Hypothermia therapy for perinatal ischemic brain injury -- 10. Clinical Procedure of Cell Therapy (Cord blood collection) -- 11. Clinical Procedure of Cell Therapy (Separation and infusion) -- 12. Cell therapy for adult infarction -- 13. Clinical trials on cell therapy for perinatal brain injury: Challenges and opportunities -- 14. A new prospective cell therapy for neonatal brain injury.
520 _aThis book provides a wealth of insights, advances and new perspectives on cell therapy for different types of neonatal ischemic disease, such as Hypoxic-Ischemic Encephalopathy (HIE), Periventricular Leukomalacia (PVL) and neonatal infarction. These diseases pose serious challenges for neonatologists and neurologists, because the severe sequelae lead to decreasing QOL for patients and their families. Accordingly, new treatments for neonatal ischemic diseases are needed all over the world. The book develops new effective therapies combined with hypothermia therapy, an established treatment for HIE. After reviewing past approaches, it presents cutting-edge topics in cell therapy, one of the most promising candidates for treating neonatal ischemic disease. Cell Therapy for Neonatal Ischemic Disease will offer readers a better understanding of the current state of the art in this field from bench to bedside, and inspire researchers and physicians to further explore this evolving therapy.
988 _aEBSPRINGER_MEDICINA_FEB2019
650 7 _2embne
_aPersonas con disfunción cerebral
_9669455
650 7 _2embne
_9142222
_aPerinatología
700 1 _aShintaku, Haruo
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aOka, Akira
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aNabetani, Makoto
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
_0http://id.loc.gov/authorities/names/no2005046756
_9106996
776 0 8 _iPrinted edition:
_z9789811014116
776 0 8 _iPrinted edition:
_z9789811014130
776 0 8 _iPrinted edition:
_z9789811338205
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-10-1412-3
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
998 _db
_feng
_ggw
_h0
_zSI